mer
hpv
crpv
ire
rna
adjuv
vaccin
alum
b
r
c
ideal
adjuv
increas
vaccin
efficaci
balanc
respons
safe
use
recombin
proteinbas
vaccin
usual
formul
aluminum
alum
base
adjuv
ensur
adequ
immun
respons
howev
use
alum
trigger
immun
induct
henc
optim
although
adjuvant
rna
report
systemat
overal
investig
efficaci
lack
found
singl
strand
rna
term
rna
adjuv
deriv
cricket
paralysi
viru
intergen
region
intern
ribosom
entri
site
induc
express
variou
adjuvantfunctionrel
gene
type
interferon
ifn
tolllik
receptor
tlr
cell
activ
leukocyt
chemotaxi
human
peripher
blood
mononuclear
cell
furthermor
innat
ifn
transcriptom
profil
pattern
similar
liveattenu
yellow
fever
vaccin
suggest
proteinbas
vaccin
formul
use
rna
adjuv
function
liveattenu
vaccin
applic
rna
adjuv
mous
enhanc
efficaci
middl
east
respiratori
syndrom
spike
protein
proteinsubunit
vaccin
human
papillomaviru
protein
viruslik
particl
vaccin
activ
innat
immun
respons
enhanc
papc
chemotaxi
lead
balanc
respons
moreov
combin
alum
rna
adjuv
synergist
induc
humor
cellular
immun
respons
endow
longterm
immun
therefor
rna
adjuv
broad
applic
use
convent
vaccin
improv
vaccin
efficaci
qualit
quantit
although
inactiv
proteinbas
vaccin
long
use
prevent
spread
variou
pathogen
success
elicit
weak
immun
respons
short
immun
durat
sever
safeti
issu
therefor
research
focus
identifi
antigen
compon
respons
immunogen
order
gener
safer
effect
vaccin
howev
purifi
recombin
antigen
gener
show
poor
immunogen
overcom
immunostimulatori
agent
ie
adjuv
ad
vaccin
induc
robust
immun
respons
vaccin
antigen
abbrevi
apc
antigen
present
cell
dc
dendrit
cell
helper
tlr
tolllik
receptor
ifn
interferon
ssrna
singlestrand
rna
il
interleukin
tfh
follicular
helper
rig
retino
acidinduc
gene
iress
intern
ribosom
entri
site
crpv
cricket
paralysi
viru
igr
intergen
region
mer
middl
east
respiratori
syndrom
cov
coronaviru
hpv
human
papillomaviru
dln
drain
lymph
node
nab
neutral
antibodi
vlp
viruslik
particl
tg
transgen
wt
wildtyp
elisa
enzymelink
immunosorb
assay
prnt
plaquereduct
neutral
test
pfu
plaqueform
unit
elispot
enzymelink
immunospot
hpbmc
human
peripher
blood
mononuclear
cell
tnf
tumor
necrosi
factor
myeloid
differenti
primari
respons
aluminum
hydroxid
alum
wide
use
adjuv
sever
human
vaccin
report
alum
inject
lead
rapid
accumul
neutrophil
cell
form
lump
compos
neutrophil
extracellular
trap
induc
lysosomemedi
lysi
distort
plasma
membran
antigen
present
cell
apc
andor
rapidli
induc
synthesi
cytokineschemokin
final
activ
inflammasom
trigger
secret
process
might
contribut
adjuv
effect
alum
howev
confirm
requir
addit
alum
induc
profound
helper
respons
along
antibodi
product
howev
alum
induc
respons
sometim
stimul
autoimmun
upregul
ige
present
sinc
classic
adjuv
sole
induc
respons
new
adjuv
capabl
promot
respons
requir
increas
cellmedi
respons
nonclass
adjuv
tolllik
receptor
tlr
ligand
stimul
product
type
interferon
ifn
proinflammatori
cytokin
type
ifn
facilit
antigen
present
major
histocompat
complex
class
iii
lead
enhanc
cytotox
cell
respons
well
cell
respons
sinc
first
use
adjuv
inactiv
japanes
enceph
viru
jev
vaccin
effici
promot
neutral
antibodi
nab
ifn
product
resist
jev
infect
poli
c
deriv
wide
use
develop
variou
vaccin
addit
rnaseresist
poli
c
stabil
polyllysin
poli
iclc
shown
strong
adjuvant
microbi
mimick
induc
innat
immun
respons
human
despit
strong
adjuvant
poli
c
concern
induct
advers
excess
immun
respons
autoimmun
diseas
difficulti
standard
mass
product
previou
studi
poli
cinduc
massiv
type
ifn
shown
critic
pathogenesi
lupu
moreov
repeat
administr
poli
c
deriv
poli
iclc
carboxymethylcellulos
show
sever
pathogen
result
develop
tuberculosi
mice
singlestrand
rna
ssrna
function
vaccin
adjuv
promot
respons
induct
ifna
interleukin
il
dc
sendai
virusderiv
defect
interf
rna
activ
innat
immun
respons
lead
increas
efficaci
inactiv
influenza
vaccin
addit
nucleosidemodifi
influenza
mrna
vaccin
show
adjuv
effect
induc
antigenspecif
follicular
helper
tfh
cell
germin
center
b
cell
respons
recent
ssrna
formul
carrier
show
immuneenhanc
effect
tlr
retino
acidinduc
gene
rig
like
helicas
signal
pathway
although
studi
demonstr
ssrna
could
function
adjuv
systemat
investig
effect
applic
proteinbas
inactiv
vaccin
lack
therebi
prevent
widespread
clinic
adopt
previous
develop
novel
ssrnaexpress
platform
sever
viral
intern
ribosom
entri
site
iress
studi
investig
adjuv
effect
ssrna
rna
adjuv
deriv
cricket
paralysi
viru
crpv
intergen
region
igr
ire
formul
rna
adjuv
proteinsubunit
vaccin
middl
east
respiratori
syndrom
mer
coronaviru
cov
viruslik
particl
vaccin
human
papillomaviru
hpv
show
rna
adjuv
induc
balanc
respons
innat
immun
moreov
expect
rna
adjuv
work
recruit
apc
increas
antigen
uptak
inject
site
retent
drain
lymph
node
dln
furthermor
show
rna
adjuv
enhanc
humor
cellular
immun
respons
promot
antigenspecif
neutral
antibodi
nab
respons
ultim
endow
longterm
immun
result
demonstr
rna
adjuv
could
develop
gener
safe
effect
adjuv
applic
proteinbas
vaccin
type
immun
mer
solubl
protein
vaccin
hpv
viruslik
particl
vlp
vaccin
femal
balbc
mice
purchas
daehan
biolink
merscov
challeng
tg
mice
old
maintain
biosafeti
level
facil
korea
zoonosi
research
institut
chonbuk
nation
univers
follow
guidelin
institut
anim
care
use
committe
solubl
mer
spike
protein
vaccin
provid
intern
vaccin
institut
seoul
korea
mer
protein
express
insect
cell
transmembran
domain
compris
first
amino
acid
merscov
strain
genbank
vlp
contain
hpv
mixtur
type
obtain
sk
bioscienc
seoul
korea
express
insect
cell
due
patent
issu
detail
inform
hpv
vaccin
unavail
dna
platform
design
use
igr
ire
latepolyadenyl
signal
sequenc
supplementari
fig
dna
templat
linear
noti
vitro
transcript
perform
use
ez
high
yield
vitro
transcript
kit
enzynom
daejeon
korea
hiscrib
quick
high
yield
rna
synthesi
kit
new
england
biolab
ipswich
usa
see
supplementari
method
detail
mer
protein
vaccin
studi
wt
mice
old
inocul
intramuscularli
upper
thigh
twice
week
interv
follow
formul
mg
mer
protein
vaccin
withwithout
mg
rna
adjuv
mg
alum
thermo
fisher
scientif
waltham
usa
wildtyp
wt
mice
mg
mer
protein
vaccin
withwithout
mg
rna
adjuv
mg
alum
brentann
frederikssund
denmark
mice
vaccin
studi
balbc
mice
old
inocul
intramuscular
inject
upper
thigh
three
time
week
interv
mg
withwithout
mg
protamineformul
rna
adjuv
mg
alum
antigenspecif
mous
serum
measur
elisa
plate
corn
corn
yn
usa
coat
ngwell
mer
protein
ngwell
vaccin
incub
overnight
see
supplementari
method
detail
serum
merscov
infect
mice
serial
dilut
serumfre
medium
virusserum
mixtur
prepar
mix
plaqueform
unit
pfu
merscov
use
dilut
serum
sampl
incub
hpvspecif
nab
titrat
perform
describ
previous
see
supplementari
method
detail
splenocyt
immun
mice
gp
end
experi
stimul
lgwell
antigen
h
elispot
detect
ifncsecret
cell
perform
accord
manufactur
instruct
mabtech
stockholm
sweden
surfac
stain
splenocyt
isol
immun
cell
muscl
lymph
node
stain
follow
antibodi
min
room
temperatur
clone
ebiosci
clone
bio
legend
clone
bd
bioscienc
clone
invitrogen
clone
bd
bioscienc
clone
invitrogen
clone
mel
bd
bioscienc
clone
bio
legend
clone
invitrogen
clone
bd
bioscienc
clone
ebiosci
cell
fix
paraformaldehyd
analyz
use
fac
canto
ii
flow
cytomet
bd
bioscienc
data
analyz
use
flowjo
treestar
determin
polyfunct
cell
isol
splenocyt
restimul
lgwell
mer
spike
protein
ngwell
peptid
mixtur
evalu
cytotox
degranul
activ
cell
clone
bd
bioscienc
ad
cultur
medium
brefeldin
golgiplug
bd
bioscienc
monensin
golgistop
bd
bioscienc
ad
h
later
anoth
h
incub
splenocyt
first
stain
ethidium
monoazid
sigma
stain
clone
clone
clone
bd
bioscienc
stain
cell
permeabil
use
cytofixcytoperm
kit
ebiosci
stain
antiifncapc
antitnfafitc
clone
bd
bioscienc
clone
invitrogen
clone
ebiosci
cell
fix
paraformaldehyd
analyz
use
lsrii
flow
cytomet
bd
bioscienc
cell
posit
variou
combin
cytokin
degranul
analyz
quantifi
use
boolean
gate
function
flowjo
treestar
laserscan
intravit
confoc
microscop
ivmc
ivim
technolog
use
visual
dendrit
cell
monocyt
recruit
mice
jackson
laboratori
bar
harbor
usa
stock
endogen
express
gfp
dendrit
cell
monocyt
use
mice
deepli
anesthet
intraperiton
inject
zoletil
mgkg
rompun
mgkg
imag
mous
bodi
temperatur
maintain
homeotherm
control
physiosuit
righttemp
kent
scientif
mixtur
alexa
fluor
thermo
fisher
scientif
either
rna
adjuv
pb
subcutan
inject
mous
ear
skin
use
microinjector
seri
syring
hamilton
label
vasculatur
antibodi
bd
bioscienc
conjug
alexa
flour
thermo
fisher
scientif
inject
intravascularli
h
imag
use
distinct
vasculatur
fluoresc
signal
alexa
fluor
landmark
repetit
imag
inject
site
recruit
dendrit
cell
irregular
outlin
monocyt
round
outlin
imag
vivo
min
h
inject
recruit
dendrit
cell
monocyt
quantifi
calcul
area
occupi
cell
use
imagej
plugin
nih
stimul
human
peripher
blood
mononuclear
cell
hpbmc
rna
adjuv
h
concentr
tumor
necrosi
factor
tnf
ifnc
analyz
use
magnet
luminex
screen
assay
kit
r
system
minneapoli
mn
usa
accord
manufactur
instruct
examin
effect
cell
mice
old
inocul
intramuscular
inject
twice
interv
mg
mer
protein
vaccin
mg
rna
adjuv
follow
inocul
intraperiton
inject
mg
kg
antimous
yt
bioxcel
west
lebanon
nh
usa
andor
mgkg
antimous
yt
bioxcel
everi
first
immun
oneway
analysi
varianc
use
assess
signific
differ
among
treatment
group
signific
treatment
effect
tukey
hsd
test
use
compar
multipl
group
mean
addit
histomorphometr
valu
express
mean
standard
deviat
sd
multipl
comparison
test
differ
treatment
group
conduct
leven
test
indic
signific
deviat
varianc
homogen
data
obtain
analyz
leastsignific
differ
multicomparison
test
signific
deviat
varianc
homogen
detect
use
leven
test
nonparametr
kruskalw
htest
conduct
signific
differ
detect
kruskalw
htest
mannwhitney
utest
conduct
post
hoc
analysi
statist
analys
conduct
use
spss
window
releas
spss
inc
assess
signific
differ
two
group
student
ttest
use
differ
consid
signific
p
rna
adjuv
affect
gene
relat
innat
immun
respons
cell
activ
chemotaxi
similar
poli
c
hpbmc
investig
adjuv
effect
treat
hpbmc
rna
adjuv
use
poli
c
posit
control
find
rna
adjuv
induc
cytokin
releas
similar
poli
c
fig
compar
transcriptom
profil
rna
adjuvantand
poli
c
treat
hpbmc
rna
sequenc
control
poli
c
rna
adjuv
treatment
form
separ
cluster
without
bia
fig
scatter
plot
gene
profil
confirm
chang
geneexpress
rna
adjuv
poli
c
group
greater
control
rna
adjuv
group
posttreat
p
foldchang
fig
investig
biolog
pathway
associ
gene
affect
rna
adjuv
analyz
geneexpress
pattern
use
kyoto
encyclopedia
gene
genom
databas
http
wwwgenomejpkeggmapperhtml
fig
network
gene
involv
pathway
base
string
databas
fig
similar
biolog
pathway
affect
rna
adjuv
poli
c
treatment
supplementari
fig
heat
map
innateimmunerel
gene
type
ifn
tlrmyeloid
differenti
primari
respons
well
cell
activ
leukocyt
chemotaxi
indic
similar
express
pattern
two
group
fig
nfjb
among
tlr
relat
gene
induc
among
cell
activ
relat
gene
stat
among
multipl
transcript
factor
function
key
player
rna
adjuv
group
fig
yellow
fever
vaccin
success
liveattenu
vaccin
durat
protect
immun
singl
immun
year
compar
transcript
profil
induc
rna
adjuvanttr
hpbmc
posttreat
pbmc
obtain
patient
postimmun
approxim
innat
immun
respons
type
ifnrel
gene
key
factor
contribut
superior
vaccin
show
similar
chang
express
pattern
two
sampl
fig
b
induct
import
upstream
immun
transcript
factor
target
differ
effector
immun
respons
vaccin
interestingli
increas
level
respons
rna
adjuv
respons
fig
indic
rna
adjuv
affect
import
transcript
factor
play
key
role
efficaci
rna
adjuv
increas
apc
retent
dln
promot
select
antigenspecif
b
cell
epitopepres
apc
process
similar
observ
follow
treatment
poli
c
fig
furthermor
vivo
timelaps
imag
clearli
show
rna
adjuv
summon
immun
cell
mostli
dc
irregular
outlin
inject
site
fig
c
consist
heat
map
describ
upregul
leukocyt
chemotaxi
fig
indic
rna
adjuv
enhanc
antigen
uptak
dc
inject
site
promot
epitop
present
dln
confirm
adjuv
effect
vivo
formul
mer
spike
protein
use
immun
wt
mice
withwithout
alum
fig
first
immun
show
highest
level
indic
respons
boost
week
second
immun
show
similar
level
convers
indic
respons
induc
fig
suggest
rna
adjuv
induc
respons
moreov
show
highest
nab
level
indic
strong
respons
show
similar
level
fig
interestingli
show
higher
number
ifnc
secret
cell
follow
stimul
mer
protein
compar
fig
indic
rna
adjuv
induc
mer
proteinspecif
respons
moreov
observ
elev
number
polyfunct
cell
fig
result
suggest
rna
adjuv
promot
cell
respons
especi
respons
consequ
induc
antigenspecif
cellular
immun
respons
furthermor
administ
alum
along
rna
adjuv
gener
synergist
effect
lead
increas
nab
level
stimul
balanc
respons
investig
protect
effect
immun
mer
protein
formul
rna
adjuv
plu
alum
fig
immun
mice
surrog
mous
model
mer
challeng
although
bodi
weight
immedi
reduc
quickli
recov
challeng
fig
observ
surviv
fig
possibl
due
suffici
nab
level
deriv
boost
immun
although
show
lower
nab
level
rel
mice
supplementari
fig
investig
longterm
immun
effect
rna
adjuv
immun
mice
hpv
vaccin
vlp
vaccin
rna
adjuvantcontain
gene
rna
adjuvanthpv
supplementari
fig
protamin
use
condens
compon
rnacation
peptid
complex
alum
fig
first
immun
level
similar
wherea
level
higher
fig
three
dose
week
first
immun
show
similar
level
fig
howev
show
higher
nab
level
hpv
similar
level
hpv
lower
level
hpv
fig
furthermor
frequenc
ifncsecret
cell
among
splenocyt
stimul
protein
significantli
higher
suggest
maintain
activ
respons
even
postimmun
fig
indic
rna
adjuvanthpv
help
maintain
longlast
humor
cellular
immun
respons
result
indic
rna
adjuv
induc
cell
activ
express
gene
well
balanc
respons
investig
process
wt
mice
immun
mer
protein
rna
adjuv
alum
expect
level
ko
mice
lower
wt
mice
first
immun
fig
howev
increas
ko
mice
second
immun
fig
suggest
rna
adjuv
might
partial
overcom
loss
induct
via
boost
mous
embryon
fibroblast
treat
rna
adjuv
posit
control
agonist
poli
c
show
induct
rigi
melanoma
differentiationassoci
protein
phosphoryl
interferon
regulatori
factor
tankbind
kinas
activ
kinas
downstream
molecul
rigilik
receptor
pathway
supplementari
fig
suggest
activ
rna
adjuv
may
critic
depend
pathway
activ
rna
adjuv
may
induc
multipl
mechan
bypass
signal
pathway
pathway
involv
rigilik
receptor
one
pattern
recognit
receptor
prr
investig
necess
cell
activ
respons
respect
deplet
mous
spleen
fig
supplementari
fig
mice
show
signific
reduct
level
wherea
mice
show
reduct
level
reduc
level
moreov
mice
lack
show
reduct
level
fig
indic
depend
upon
cell
activ
alon
wherea
depend
cell
activ
moreov
ifncsecret
cell
repres
respons
treatment
mix
cellepitop
peptid
induc
fig
data
show
rna
adjuv
enhanc
antigenspecif
respons
via
signal
pathway
cell
activ
studi
demonstr
adjuv
effect
crpvigr
iresderiv
ssrna
use
proteinbas
vaccin
rna
adjuv
induc
express
gene
relat
innat
immun
respons
ifn
cell
activ
leukocyt
chemotaxi
similar
poli
c
hpbmc
howev
induct
level
lower
poli
c
gene
return
normal
level
within
h
fig
transient
induct
gene
rna
adjuv
may
evid
vaccin
safeti
similarli
previou
report
demonstr
rapid
disappear
rna
platform
within
h
inject
observ
advers
effect
autoimmun
symptom
chang
liver
function
organ
damag
rna
adjuvantimmun
mice
even
higher
dose
mgmous
data
shown
although
poli
c
superior
adjuv
safeti
concern
excess
immun
respons
repres
signific
drawback
howev
rna
adjuv
appear
overcom
safeti
issu
without
decreas
immunestimul
effect
among
key
factor
induc
rna
adjuvanttr
hpbmc
intercellular
adhes
induc
fig
particular
highli
express
cell
partial
respons
cytokin
product
cell
via
protein
kinas
c
theta
nfjb
signal
pathway
addit
stimul
natur
killer
cell
immun
promot
gener
longliv
memori
cell
furthermor
function
central
regul
innat
adapt
immun
essenti
dc
tfh
cell
memori
cell
develop
given
rna
adjuv
activ
respons
induc
longterm
immun
fig
induct
gene
might
play
import
role
immun
respons
fig
rna
adjuvanthpvformul
vlp
vaccin
induc
antigenspecif
longterm
immun
balbc
mice
intramuscularli
immun
interv
three
dose
alum
withwithout
protamineformul
rna
adjuvanthpv
overal
studi
design
b
level
measur
elisa
first
immun
data
repres
mean
standard
deviat
n
mice
c
nab
level
differ
type
vlp
immun
mice
determin
pseudoviru
prnt
week
first
immun
serum
group
n
pool
splenocyt
harvest
week
first
immun
restimul
day
withwithout
type
protein
type
frequenc
hpvspecif
ifncproduc
cell
determin
elispot
data
repres
mean
standard
deviat
n
triplic
result
acquir
one
pool
sampl
per
group
data
statist
analyz
anova
b
signific
differ
group
indic
differ
letter
alphabet
p
elispot
enzymelink
immunospot
ifn
interferon
vlp
viruslik
particl
hpv
human
papillomaviru
elisa
enzymelink
immunosorb
assay
prnt
plaquereduct
neutral
test
nab
neutral
antibodi
interestingli
found
express
gene
associ
innat
immun
respons
especi
type
ifnrel
gene
similar
rna
adjuvanttr
hpbmc
pbmc
liveattenu
patient
fig
moreov
also
import
express
induc
rna
adjuvanttr
hpbmc
similar
observ
follow
immun
essenti
molecul
antigenspecif
ifn
product
promot
b
cell
activ
data
assum
rna
adjuv
may
make
inactiv
proteinbas
vaccin
function
like
live
attenu
vaccin
howev
studi
requir
confirm
hypothesi
furthermor
mice
celldeplet
mice
show
rna
adjuv
effect
fig
consist
previou
result
data
indic
rna
adjuv
might
efficaci
induc
broad
immun
respons
mediat
signal
cell
activ
howev
prr
rna
adjuv
confin
alon
rna
adjuv
could
induc
rigilik
receptor
pathwayrel
molecul
similar
poli
c
supplementari
fig
indic
rna
adjuv
recogn
rigilik
receptor
addit
activ
immun
respons
data
accord
previou
studi
show
rna
base
adjuv
trigger
tlrand
rigilik
helicasedepend
effect
therefor
boost
rna
adjuv
may
partial
induc
respons
mice
rigilik
pathway
howev
know
pathway
induc
studi
requir
understand
detail
underli
mechan
addit
although
rna
adjuv
mediat
effect
signal
pathway
use
tlr
agonist
imiquimod
agonist
resiquimod
agonist
chemic
adjuv
control
studi
studi
focus
rnabas
adjuv
poli
c
chemic
agonistadjuv
poli
c
dsrna
show
strong
adjuvant
inactiv
proteinbas
vaccin
therefor
use
control
studi
upon
immun
mer
protein
vaccin
togeth
alum
rna
adjuv
mer
sspecif
nab
product
increas
synergist
fig
data
suggest
cell
activ
may
also
show
synergist
increas
howev
data
need
confirm
fig
addit
given
strong
immunestimul
effect
rna
adjuv
unsurpris
rna
adjuvanthpv
group
abl
maintain
hpvspecif
nab
level
respons
even
first
immun
fig
result
indic
rna
adjuv
trigger
longterm
immun
includ
humor
cellular
immun
respons
import
fea
fig
rna
adjuv
induc
respons
cell
mice
wt
mice
intramuscularli
immun
interv
two
dose
mg
mer
solubl
protein
vaccin
mg
formul
rna
adjuv
alum
mer
proteinspecif
level
measur
elisa
week
first
second
immun
data
repres
mean
standard
deviat
n
mice
b
overal
studi
design
mous
schedul
immun
treatment
c
mer
proteinspecif
level
measur
elisa
week
second
immun
data
repres
mean
standard
deviat
n
mice
frequenc
mer
proteinspecif
ifncproduc
cell
determin
elispot
treatment
cellepitop
peptid
mixtur
peptid
describ
previous
mer
protein
data
repres
mean
standard
deviat
n
triplic
result
acquir
one
pool
sampl
per
group
data
statist
analyz
anova
c
signific
differ
group
indic
differ
letter
alphabet
p
th
helper
cell
elispot
enzymelink
immunospot
spike
ifn
interferon
elisa
enzymelink
immunosorb
assay
prnt
plaquereduct
neutral
test
mer
middl
east
respiratori
viru
tlr
tolllik
receptor
ko
knockout
wt
wildtyp
ture
given
hpv
longterm
protect
effect
vaccin
use
one
rna
molecul
deriv
crpvigr
ire
absenc
target
gene
adjuv
demonstr
adjuvant
mer
protein
vaccin
rna
adjuvantcontain
target
gene
also
show
immunestimul
effect
therefor
although
previous
show
rna
platform
could
express
code
gene
rna
adjuv
includ
target
gene
critic
ensur
adjuvant
howev
rna
platform
use
rna
vaccin
need
encod
target
gene
improv
deliveri
strategi
increas
express
effici
inocul
anim
muscl
warrant
interestingli
compar
adjuvant
crpvigr
iresderiv
rna
rna
virusderiv
adjuv
includ
coxsackieviru
encephalomyocard
viru
emcv
iressderiv
rna
crpv
iresderiv
rna
show
higher
adjuv
effect
compar
emcv
iresderiv
rna
data
shown
studi
underway
effect
viral
ire
type
immun
effect
use
rna
adjuv
immun
stimul
regardless
presenc
antigenencod
gene
mani
advantag
includ
applic
proteinbas
vaccin
simpl
manufactur
procedur
easi
standard
moreov
potenti
overcom
challeng
associ
proteinsubunit
vaccin
weak
cell
activ
associ
immun
respons
consequ
promot
high
nab
level
balanc
respons
result
longterm
immun
therefor
sinc
rna
adjuv
exhibit
immuneenhanc
capac
might
valuabl
firstlin
vaccin
epidem
emerg
also
improv
proteinbas
vaccin
efficaci
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
